|
IFRD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.162180E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.304700E-03 |
| Normal-vs-Stage2 |
6.431500E-02 |
| Normal-vs-Stage3 |
5.847600E-02 |
| Normal-vs-Stage4 |
9.315600E-02 |
| Stage1-vs-Stage2 |
3.589600E-01 |
| Stage1-vs-Stage3 |
8.872000E-01 |
| Stage1-vs-Stage4 |
2.569400E-01 |
| Stage2-vs-Stage3 |
3.650800E-01 |
| Stage2-vs-Stage4 |
5.953600E-01 |
| Stage3-vs-Stage4 |
2.557600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.448900E-04 |
| Normal-vs-AfricanAmerican |
1.939960E-03 |
| Normal-vs-Asian |
3.401200E-01 |
| Caucasian-vs-AfricanAmerican |
3.983200E-01 |
| Caucasian-vs-Asian |
5.305600E-01 |
| AfricanAmerican-vs-Asian |
6.050600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.798060E-04 |
| Normal-vs-Female |
3.783600E-03 |
| Male-vs-Female |
6.680400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.441200E-03 |
| Normal-vs-Extreme_Weight |
1.396150E-03 |
| Normal-vs-Obese |
1.857650E-03 |
| Normal-vs-Extreme_Obese |
3.955800E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.281200E-01 |
| Normal_Weight-vs-Obese |
5.148800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.031800E-01 |
| Extreme_Weight-vs-Obese |
5.343000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.418600E-01 |
| Obese-vs-Extreme_Obese |
7.694800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.556300E-02 |
| Normal-vs-Age(41-60Yrs) |
8.584300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.357540E-03 |
| Normal-vs-Age(81-100Yrs) |
2.739000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.464400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.870100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.676820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.278800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.432400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.884400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63009999998298E-06 |
| Normal-VS-Type2 PRCC |
4.047200E-01 |
| Normal-VS-KIRP CIMP |
4.528500E-02 |
| Normal-VS-Unclassified PRCC |
1.139240E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.82909999982373E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.144800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.391900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.773700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.664800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.560100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.668000E-02 |
| Normal-vs-N1 |
3.316200E-02 |
| Normal-vs-N2 |
9.811000E-01 |
| N0-vs-N1 |
2.493400E-01 |
| N0-vs-N2 |
4.837200E-01 |
| N1-vs-N2 |
5.104300E-02 |
|
|
